Close Menu
It appears too many would-be customers were confusing Belgian protein biomarker company Peakadilly with a similarly pronounced street corner in London 200 miles away.
 
“Peakadilly was a very distinctive name, but we did run into some problems with it just because of its closeness with an iconic English name,” said Nick McCooke, CEO of newly renamed Pronota, referring to the London landmark Piccadilly Circus. “[There was] confusion about how it’s spelled and what the company was about.”
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.